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DIFFICULTIES IN THE DIAGNOSIS OF SCHISTOSOMIASIS IN 
PATIENTS OF THE DEPARTMENT OF TROPICAL AND 
PARASITIC DISEASES  
OF THE MEDICAL UNIVERSITY OF GDAŃSK 
JOLANTA GOLJAN 1, WACŁAW LESZEK NAHORSKI 1,  
IWONA FELCZAK-KORZYBSKA 2, AGNIESZKA WROCZYŃSKA 1, 
PRZEMYSŁAW MYJAK 1, ANDRZEJ KOTŁOWSKI 1 
Between 2002 and 2006 in the Department of Tropical and Parasitic Diseases of the 
Medical University of Gdansk 40 hospitalized patients were suspected of 
schistosomiasis on the basis of clinical manifestations, epidemiological data and 
positive serology tests (ELISA IgG).  
In spite of multiple tests, schistosoma eggs were not identified neither in stool nor 
in urine of the patients. 
Histopathological examinations of liver and colon or bladder mucosal biopsy have 
not revealed schistosoma eggs in chosen patients. 
Diagnosis confirmation in case of negative parasitic tests requires serologic tests for 
schistosomiasis. ELISA serology tests for antibodies class G were performed in all 40 
patients. In some cases the results were dubious – index in the upper limit or only 
slightly elevated. In those cases, cross reactions with Plasmodium spp. were taken into 
account. In 10 patients, serologic index for schistosomiasis was elevated during or a few 
weeks after treatment for malaria. In control tests, 4-8 weeks after the first examination, 
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serologic indexes for schistosomiasis were significantly lower or normal without 
specific treatment with praziquantel (Biltricide, Cesol). Seven patients were lost from 
follow up. 
Because of diagnostic difficulties confirmation tests with Immuno-Blot IgG were 
introduced to verify ELISA. After final clinical and serologic analysis, human 
schistosomiasis was diagnosed in 23 patients who were treated with success. 
INTRODUCTION 
Parasitic diseases are a major health hazard for people in tropical countries. Malaria 
is the most prevalent parasite disease, schistosomiasis is second. According to World 
Health Organization reports about 200 million people in 74 tropical and subtropical 
countries are infected with schistosoma worms, of these 170 million live in Africa (1). 
About 120 million are symptomatic, with 20 million having severe clinical disease. 
Number of deaths is not known but it is assumed that from hundreds of thousands to 
one million people die from schistosomiasis each year. 
Human schistosomiasis is caused by a few species: Schistosoma mansoni, S. 
haematobium, S. japonicum, S. mekongi and S. intercalatum. The main cause of 
infection is exposure to fresh water in lakes, ponds, pools or slow rivers infected with 
snails Biomphalaria and Oncomelania  which are natural hosts of Schistosoma spp. 
cercariae.  
Cercariae develop into adult flukes in 4-8 weeks and then produce eggs for the first 
time. Adult S. mansoni produces 300 eggs per day, S. japonicum around 3000 eggs per 
day. Adult flukes are 10 to over 12 mm long and live 5-10 years.  
Most infections are asymptomatic but in some cases a few weeks after infection 
high fever may develop (Katayama fever) accompanied by muscle pain and fatigue. 
Rarely acute infection may cause headache, abdominal pain, diarrhea, cough, skin rush, 
generalized limphadenopathy, hepatosplenomegaly and eosinophilia. Sometimes focal 
neurological defects may develop (2).  
In many cases symptoms develop many years after infection causing chronic 
schistosomiasis. Late signs like granulomas and fibrosis that develop in human tissue 
and are caused by schistosoma eggs. Infection with S. mansoni or S. japonicum is 
characterized by periportal fibrosis which leads to portal hypertension, gastrointestinal 
hemorrhage, splenomegaly, hypersplenism and intestinal polyposis with diarrhoea and 
the passage of blood and mucus.  Typical signs of S. haeamatobium infection in the late 
stage of the disease are bladder polyposis, hematuria, bladder scarring, urinary tract 
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calcifications, secondary renal disorders and increased frequency of bladder cancer. 
Infection with any Schistosoma species can cause pulmonary hypertension and focal 
changes in the central nervous system (http://www.emedicine.com/med./topic2071.htm, 
Nov 26,2007) 
OBJECTIVE 
The objective of this study was to: 
-  draw attention to a disease rarely diagnosed in Poland, 
-  analyze diagnostic procedures in patients suspected of schistosomiasis, 
- asses diagnostic value of serologic tests performed in patients who stayed in 
regions endemic for schistosomiasis.  
MATERIAL 
Between 2002-2006, in the Department of Tropical and Parasitic Diseases 127 
patients were hospitalized and examined for tropical diseases. Among them malaria was 
the most prevalent disease (32 patients) and schistosomiasis was in the second place.  
During this period of time, 40 patients were suspected of schistosomiasis on the 
basis of clinical manifestations, epidemiological data and positive results in ELISA IgG 
tests. Final diagnosis of schistosomiasis was made in 23 patients – 22 men aged 22-64 
years (mean age 37 years) and one woman 31 years old. All patients were Polish 
citizens. 
Most patients contracted the disease in Africa (Cameroon, Nigeria, Ghana, Ivory 
Cost, Gabon, Togo, South Africa, Zambia, Kenya, Senegal, Sierra Leone). Only three 
patients were infected in South America (Argentina, Bolivia, Peru, Chile, Mexico). 
Patients stayed in tropical countries from 2 months to 25 years. 
METHODS 
The following diagnostic tests were used: 
1. parasitic stool examination: 
- microscopic stool smear in saline and Lugol solution, 
- Kato method examination, 
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- flotation by Fuelleborn,  
- decantation. 
2. parasitic urine analysis for Schistosoma spp. eggs  
3. histopathological examination of  liver biopsy and biopsy of colon mucosa ( 
performed in the Department of Anatomopathology of the Medical University of 
Gdansk) 
4. Serologic analysis  
-       ELISA IgG (NovaTec Immunodiagnostica GmbH, Germany) – positive 
index > 2,3 
-         Immuno-Blot IgG with “Schistosoma Western blot IgG” LDBIO 
Diagnostics, France 
-        IFA tests (Indirect Fluorescent Antibody) for the presence of Plasmodium 
falciparum antibodies (3) 
Patients were treated with praziquantel 40 mg per kg given once or in two doses 
with 6-8 hours interval. All patients who came up for control examination after 4-8 
weeks were again treated with praziquantel (4). 
RESULTS 
ELISA serology tests for IgG were positive in all 40 patients (index 2,4-22,4). On 
the other hand parasitic stool and urine tests did not reveal Schistosoma spp. eggs or eggs 
and cysts of other parasites in any of the patients. The following clinical and laboratory 
parameters raised high suspicion of schistosomiasis: 
- high level of class E antibodies in 13 patients, 
- eospinophilia in 7 patients, 
- hepatomegaly in almost all patients (33), 
- splenomegaly without thrombocytopenia in 19 patients or with 
thrombocytopenia in 5 patients (hypersplenism) 
- blood in urine of unknown etiology in 3 patients. 
None of the patients had signs of the acute schistosomiasis with fever. 
All patients had a history of exposure to fresh water reservoir in regions endemic 
for schistosomiasis.  
In presented cases positive results of serologic tests for schistosomiasis (ELISA 
IgG) were the main reason for diagnosing schistosomiasis despite of negative results of 
parasitic urine and stool examinations. 
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Table 1   
Serologic tests in patients suspected of schistosomiasis, with high titers of antibodies 
against Plasmodium falciparum (untreated) 
 
No. Patient 
age 
Country/  
Duration of stay 
 
Serology for schistosomiasis 
 
ELISA IgG          Immuno-Blot IgG 
Serology for 
malaria  
IFA IgG 
 1. W.P. 
51 
Togo 
8 years 
I  – 9,2 
II - 3,2 
Negative 1:2560  
 2. M.A. 
28 
Nigeria 
6 months 
I  – 2,5 
II – negative 
     „ 1:2560 
 3. B.E. 
42 
Cameroon 
13 years 
I  - 2,7      „ 1:2560 
 4. B.T. 
39 
Kenya 
13 years 
I  – 3,3 
II – 2,5 
     „ 1:1280 
 
 5. K.F. 
36 
Gabon 
1 year 
I  – 2,6 
II – negative 
     „ Malaria 
P. falc.  
 6. S.M. 
45 
South Africa, 
7 years 
I  – 4,09 
II – 2,01 
     „ 1:2560 
 7. P.J. 
22 
Bolivia, Chile 
3 months 
I  - 2,8 
II – 2,1 
     „ 1:640 
 8. A.Z. 
44 
Sierra Leone  
6 months 
I  – 2,8 
II – negative 
     „ 1:1280 
 9. O.S. 
33 
Cameroon 
2,5 years 
I  – 2,4 
II – 2,0 
     „ 1:1280 
10. H.A. 
52 
Zambia 
4 years 
I  – 11,6 
II – 3,3 
     ,, 1:1280 
Table 2 
Patients with diagnosed and treated schistosomiasis  
 
No. Patient  
age 
Country/ 
Duration of stay 
Serology for schistosomiasis 
 
ELISA IgG        Immuno-Blot IgG 
Serology for malaria  IFA and 
leishmaniasis ELISA IgG 
Remarks 
 1. R.J. 
53 
Cameroon  
16 years 
I - 4,18 + Malaria       1:640, 
leishmaniasis (-) 
 2. S.M.  
64 
Zambia 
34 years 
I - 6,05 
II after treatment-  
3,1 
+               1:640 
                ( - ) 
hematuria 
 3. D.R. 
36 
Togo 
9 years 
I  – 9,72 
II – 4,01 
+               1:2560 
                ( - ) 
 4.  W.M. 
39 
Senegal 
2 months 
I   - 9,4 
II –10,31 
+                 ( - ) 
                ( - ) 
 5.  G.K. 
57 
Ghana 
25 years 
I   - 22,4 +                 ( - ) 
                ( - ) 
liver cirrhosis? 
 6. K.Z. 
36 
South Africa 
7 years 
I  - 3,1 
II – 4,4 
+                1:640 
 7 M.S. 
41 
Asia, Africa 
multiple stays 
I  -2,9 
II -2,3 
+                 ( - ) 
                ( - ) 
hematuria 
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 8. J.R. 
46 
Zambia  
13 years 
I – 3,4 +                 ( - ) 
                ( - ) 
 9. S.S. 
43 
Zambia  
12 years 
I  - 2,54 +                1: 1280 
                ( - ) 
10. P.M. 
36 
South America  
9 years 
I  -3,88 +                 ( - ) 
hematuria 
11. F.A. 
52 
Angola 
18 years 
I  -2,64 +                1:320 
12. C.B. 
36 
Ghana  
6 years 
I  - 4,84 
II –4,11 
+                 ( - ) 
                ( - ) 
13. G.M. 
39 
South Africa 
10 years 
I  - 6,7 
II –3,66 
+                1:2560 
                ( - ) 
Liver cirrhosis 
14. B.E. 
51 
Cameroon  
10 years 
I  - 3,95 +                 1:320 
                 ( - ) 
Liver cirrhosis? 
15. C.Ł. 
23 
South America 
6 months 
I  - 4,7 +                 1:640 
                 ( - ) 
16. Ł.K. 
48 
Angola  
10 years 
I  - 5,3 
 
+                  ( - ) 
                 ( - ) 
17. W.R. 
37 
South America 
8 years 
I  - 5,8 
II –2,92 
+                 1:160 
                 ( - ) 
18. S.H. 
31 
Cameroon  
3 years 
I  - 2,9 +                  1:80 
                 ( - ) 
19. O.K. 
18 
South East Asia 
4 years 
I  - 2,7 
II –2,07 
+                  ( - ) 
                 ( - )  
20. S.J. 
60 
Turkey 
Few months 
I  - 3,4 
II  -2,4 
+                  ( - ) 
                 ( - ) 
21. S.M. 
45 
South Africa 
9 years 
I   - 4,09 +                 1:2560 
                 ( - ) 
22. S.J. 
42 
Chad, South Africa 
5 years 
I   - 9,7 
II – 6,6 
+                 1:320 
                 ( - ) 
23. J.R. 
48 
Tanzania 
9 years 
I   - 3,4 
II – 3,1 
+                  ( - ) 
                 ( - ) 
 
Liver biopsy was performed in two cases, one patient had biopsy of colon mucosa 
but no parasite eggs were found. In three patients with hematuria urologist ordered 
cystoscopy but it did not reveal the site of bleeding. No bladder mucosal biopsy was 
taken. In three patients with severe thrombocytopenia (below 60000/ml) neither liver 
biopsy nor colon mucus biopsy were made. 
In 10 patients with high levels of antibodies against Plasmodium spp. minimal or 
slight elevation of serologic indexes against Schistosoma spp. was found (table 1). 
Specificity of this results was dubious and it could be a result of cross reaction, so those 
patients were excluded from treatment for schistosomiasis. In control examination after 
4-8 weeks, serologic indexes were normal or lowered which might be the result of 
unspecific reaction. Seven patients with borderline serologic indexes in ELISA test (2,3-
2,4) did not show up for control tests. Results of screening test performed with ELISA 
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were confirmed by Immuno-Blot IgG. This method confirmed Schistosoma spp. 
infection in 23 cases (table 2). Some of those patients were examined retrospectively. 
Observation lasting from several months to few years (5 patients) confirmed good 
results of antiparasitic treatment with regression of clinical symptoms and signs and 
normalization of laboratory tests except from 3 patients with progressing disease (liver 
cirrhosis). Gradual normalization of serologic tests was also observed.  
DISCUSSION 
Parasitic infections might present a diagnostic difficulty because in some patients it 
is difficult to detect developmental stages of parasites. Such situation is most common 
in patients traveling to tropical countries, in cases of infections with low parasite burden 
and in cases of past infections (6). 
Lack of positive result of the stool and urine parasitic examinations does not 
exclude Schistosoma  spp. infection because eggs excretion begins, depending on 
species, 4-8 weeks after infection and afterwards is irregular with intensity depending 
on parasite burden.  
Parasitological  diagnosis of Schistosoma spp. requires repeated examinations of 
stool and urine for eggs of worms and histopathological examinations 
(http://www.emedicine.com/med/topic1823.htm Aug 23, 2004). 
Diagnostic difficulties described above were observed in patients hospitalized in 
our clinic. Patients had clinical signs suggesting schistosomiasis: splenomegaly, low 
platelet count, hepatomegaly, portal hypertension and hematuria of unknown etiology. 
Diagnosis of parasitic infection was also confirmed in other tests: eosinofilia, X-ray, 
ultrasound, CT, endosocopy and histopathological examinations. 
In these cases serological findings are the most important tool for diagnosing 
schistosomiasis. In endemic regions serologic tests with different sensitivity and 
specificity are used, that test antibodies as well as antigens of different developmental 
stages of the parasite (5). In countries where schistosomiasis is rarely diagnosed i.e. in 
Poland, only chosen tests are used like for example screening test and in case of positive 
results confirmation test. This type of diagnosis is used by different authors, for 
example Tsang (7) proposes this kind of diagnosis in people coming from tropical 
countries.     
Most doubts were caused during interpretation of serologic tests positive for 
schistosomiasis (ELISA IgG) in patients suffering or recovering from malaria, when 
titers against Plasmodium falciparum were high. Results of serologic tests in such cases 
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may be false positive because of cross reactions with other parasites for example 
Plasmodium spp. as well as Leishmania spp. or some helminthiases (8).  
Introduction of confirmation test - Immuno-Blot IgG – which detects class G 
antibodies specific for Schistosoma spp. and is a specific and sensitive method, has 
facilitated serologic diagnosis of schistosomiasis, eliminating nonspecific cross 
reactions. Because patients in the presented cohort had no acute infections only class G 
antibodies were identified. Immuno-Blot has the advantage of early detection of 
schistosomiasis, 3-4 weeks from infection when class M antibodies are produced  (9). 
This test is recommended as serologic marker confirming infection and indicating 
treatment effectiveness.   
Immuno-Blot enabled verification of positive results of current and previous ELISA 
IgG . Among 40 patients with high ELISA indexes, in 23 cases infection was confirmed 
with Immuno-Blot IgG. All patients were treated with success. Results showed lower 
specificity of ELISA IgG with some false positive results. 
Clinical picture of schistosomiasis may be modified by other diseases for example 
mononucleosis or viral hepatitis type B or acute pyelonephritis which was observed in 
our patients. Symptoms of accompanying diseases masked the parasitic disease and 
made the diagnosis more difficult.  
CONCLUSIONS     
1. In 2002-2006, 127 patients with suspected parasitic diseases  were hospitalized 
in our clinic. Out of them, in 40 patients schistosomiasis was suspected . Finally, 
in 23 of them schistosomiasis was diagnosed, and they were treated accordingly. 
2. In 10 patients (25%) with high titer of antibodies against Plasmodium spp. High 
serologic indexes for schistosomiasis in ELISA IgG were a consequence of cross 
reactions. 
3. In patients with suspected  infestation with Schistosoma spp. flukes, with 
negative parasitic examinations of stool, urine and negative tissue biopsy, 
positive results of screening serologic tests had to be verified using confirmation 
test with Western blot method. 
4. Because of serious consequences of untreated schistosomiasis, treatment is 
justified in chosen cases with only indirect evidence of this parasitic infection 
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